Risedronate gastrointestinal absorption is independent of site and rate of administration.
- 1 January 1998
- journal article
- clinical trial
- Published by Springer Nature in Pharmaceutical Research
- Vol. 15 (2), 228-232
- https://doi.org/10.1023/a:1011910517200
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Bisphosphonates: A review of their pharmacokinetic propertiesBone, 1996
- Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animalsBiopharmaceutics & Drug Disposition, 1995
- On the Absorption of Alendronate in RatsJournal of Pharmaceutical Sciences, 1994
- Fortnightly Review: The therapeutic use of bisphosphonatesBMJ, 1994
- Biologic, histologic and densitometric effects of oral risedronate on bone in patients with multiple myelomaBone, 1994
- Pharmacokinetic evaluation of pamidronate after oral administration: A study on dose proportionality, absolute bioavailability, and effect of repeated administrationCalcified Tissue International, 1993
- Acute changes in calcium homeostasis during treatment of primary hyperparathyroidism with risedronate.Journal of Clinical Endocrinology & Metabolism, 1993
- Oral tiludronate: Pharmacological properties and potential usefulness in Paget's disease of bone and osteoporosisBone, 1992
- Dose-dependent absorption of disodium etidronateJournal of Pharmacy and Pharmacology, 1985
- Clodronate kinetics and bioavailabilityClinical Pharmacology & Therapeutics, 1982